SCHEMBL4901443

SCHEMBL4901443

CN(C)c1ccc(C=NCCN=Cc2ccc(N(C)C)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.59
KMT2A Q03164 3/20 0.59
KDM4E B2RXH2 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
MAPT P10636 2/20 0.59
ALOX15 P16050 2/20 0.59
HSD17B10 Q99714 2/20 0.59
MEN1 O00255 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
TP53 P04637 1/20 0.59
THRB P10828 1/20 0.59
MAPK1 P28482 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
GLA P06280 1/20 0.53
GRIN2D O15399 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901434 1.00 ALDH1A1 (0.59) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL15367607 0.90 ALDH1A1 (0.61) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL4602953 0.88 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL4602955 0.88 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL465253 0.87 ALDH1A1 (0.51) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL1133259 0.87 ALDH1A1 (0.51) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL12391383 0.84 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL19810568 0.84 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL19810569 0.84 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EL3MBTL1MAPT
SCHEMBL19821404 0.84 ALDH1A1 (0.52) ALDH1A1KMT2AKDM4EL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853352-B2 Functionalized polymer and method for making BRIDGESTONE CORPORATION (JP) 2014-10-07 US disclosed
US-20080154020-A1 introducing imine compounds into carbanionic (living) polymers, that can interact with particle filler such as carbon black and silica BRIDGESTONE CORPORATION (JP) 2008-06-26 US disclosed
US-20050234239-A1 Method of forming a carbon-carbon or carbon-heteroatom linkage SHASUN PHARMA SOLUTIONS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234239-A1 Method of forming a carbon-carbon or carbon-heteroatom linkage AOC1, AOC3, NUDT1 ALDH1A1 436/4885KMT2A 1997/4885KDM4E 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.